Bamlanivimab (LY-CoV555) is the First COVID-19 Therapeutic Made Available to the Public by the FDA
Read More
Carterra Supercharges Antibody Discovery Workflows for LakePharma with High-Throughput SPR
Read More
Carterra’s Scientist to Scientist Series: Daniel Bedinger and Tom Yuan from Twist Bioscience
Watch Interview
Carterra Helps Provide Breakthrough Analysis for Understanding the Immunity of COVID-19 Patients by Scientists in Europe
Watch the Webinar
Carterra has been Selected by the Gates Foundation to Help Solve the COVID-19 Pandemic
Watch Video
Carterra Eliminates Bottlenecks in mAb Drug Discovery
Read More
Addressing Viral Pandemics Such as COVID-19 Using the Carterra LSA
Read More
Speeding Antibody Screening for Drug Development with Carterra’s LSA
Read More
Discovering an Antibody’s Therapeutic Fingerprint Using the Carterra LSA
Read More
Accelerating Biotherapeutic Discovery with Carterra’s LSA
Read More
